Hussman Econometrics Advisors »

Syndax Pharmaceuticals shares owned by Hussman Econometrics Advisors

Quarter-by-quarter ownership of Syndax Pharmaceuticals (SNDX) shares owned by Hussman Econometrics Advisors from 13F filings

Historical chart of Hussman Econometrics Advisors investment in Syndax Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Syndax Pharmaceuticals held by Hussman Econometrics Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Syndax Pharmaceuticals by Hussman Econometrics Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.8M 84k 21.86

More positions owned by Hussman Econometrics Advisors

Pepsi (PEP)
Ubiquiti (UI)
Incyte Corporation (INCY)
ViaSat (VSAT)
Neurocrine Biosciences (NBIX)
Biogen Idec (BIIB)
Hershey Company (HSY)
Cimpress Shs Euro (CMPR)
J Global (ZD)
United Natural Foods (UNFI)
Ulta Salon, Cosmetics & Fragrance (ULTA)
Campbell Soup Company (CPB)
General Mills (GIS)
Teradata Corporation (TDC)
Dollar General (DG)

View all positions for Hussman Econometrics Advisors

Top funds holding Syndax Pharmaceuticals

BlackRock
Kynam Capital Management
Goldman Sachs Group
State Street Corporation
Bank of America Corporation
Vanguard Capital Management
Deerfield Management Company
Eversept Partners
Geode Capital Management
Hood River Capital Management
Kingdon Capital Management
Franklin Resources
Millennium Management
Vanguard Portfolio Management
UBS Group

View all funds holding Syndax Pharmaceuticals